Error: Could not add to watchlist. X

DekaLux-BioTech

+ Watchlist
DKXBICF:LX
450.02
EUR
8.33
1.82%
As of 00:59:30 ET on 09/02/2015.
Fund Type
FCP
52Wk Range
310.41 - 557.66
1 Yr Return
38.41%
YTD Return
14.92%
Previous Close
458.35
52Wk Range
310.41 - 557.66
1 Yr Return
38.41%
YTD Return
14.92%
Fund Type
FCP
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
-
NAV (on 09/02/2015)
450.02
Total Assets (m EUR) (on 09/02/2015)
304.658
Inception Date
06/02/2008
Last Dividend (on 06/30/2014)
-
Dividend Indicated Gross Yield
-
Fund Managers
ROGER VOGT
Front Load Fee
3.75%
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
1.25%
Expense Ratio
1.47%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 248.37 k 25.67 m 7.65
Biogen Inc 62.78 k 22.27 m 6.63
Amgen Inc 163.03 k 22.13 m 6.59
Celgene Corp 211.56 k 21.76 m 6.48
Regeneron Pharmaceuticals Inc 47.33 k 21.40 m 6.37
Mylan NV 238.20 k 14.42 m 4.30
Illumina Inc 65.78 k 12.60 m 3.75
Vertex Pharmaceuticals Inc 107.65 k 11.76 m 3.50
Alexion Pharmaceuticals Inc 71.28 k 11.34 m 3.38
BioMarin Pharmaceutical Inc 77.38 k 9.17 m 2.73
Profile
DekaLux-BioTech is an open-end fund incorporated in Luxembourg. The objective is growth. The Fund invests in equity securities worldwide, that are issued by companies involved in the discovery, research, development, production, distribution, and marketing of biotechnological products for medical applications.
ADDRESS
Deka International SA
5, rue des Labours
L-1912 Luxembourg
Luxembourg
PHONE
352-3409-39 Tel